Biotech is our business

Strategic, insightful and proactive practical support across your product journey. You're in safe hands.

Get In Touch Discover Insights

The Biopharma Excellence team has deep experience with cell and gene therapies and is working hand in hand with us to help realize our ambitious vision.

Where do you need our help?

Developing your drug candidate
Navigating the international regulatory landscape
Getting a new therapy into clinical trials
Applying for marketing authorizations
Science huddle logo

The Science Huddle: 20 years of Biosimilars: Are We on the Right Track?

For nearly 20 years, biosimilars have been at the center of a great debate with 2022 seen as a pivotal point as more of these biologic similars came to market. The debate has progressed from viability and feasibility to sustainability with cost, regulatory guidelines, incentives, efficacy, and patent expirations at the center of today’s industry discussion. As more biosimilars prove they can deliver new competition and lower costs to patient-critical treatments, the dialogue is shifting.

Microscope and slide

Bridging the Biotech / Regulator Divide


We help dynamic biopharma companies bring innovative new therapies to market in the smartest, smoothest and safest way possible.

We work closely with biopharma businesses, international regulators and health authorities, and potential investors, to confidently optimize the market potential of cutting-edge biotech innovation.

Our team is a fusion of three scientific powerhouses, Pharmalex, ERA Consulting and Biopharma Excellence – under the PharmaLex brand.  We combine 35+ years of empirical experience and respected regulator relationships.





Health Authorities

Biopharma Excellence are pioneers. They’re one of the first ‘recognizable names’ in this industry. They bring entrepreneurial spirit.
Senior Vice President, Pioneer Engineered iPSC
Something that really sets Biopharma Excellence apart is its people. They’re scientists, but much more than that.
Senior Vice President, CMC, Gene Therapy Company
The team at Biopharma Excellence are powerful story-builders and story-tellers. They write submissions regulators WANT to read.
Chief Executive Officer, Large Molecule Biotech Company

Insights Hub

Sharing insights, questioning norms, asking the right questions - we'll never lose sight of what you're striving for. Our insight and expertise will help you bring the most innovative therapies within reach of patients around the world.
Placeholder Image

Cell & Gene Therapy: Maximizing Commercialization Potential

How to Navigate the Less Obvious Barriers to Brining Advanced & Highly Targeted Treatments to

Start a conversation today


    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more